BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 15 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -38.1% | 18,400 | +0.5% | 0.00% | – |
| Q2 2022 | $21,000 | -91.9% | 18,300 | -79.7% | 0.00% | – |
| Q2 2021 | $259,000 | -78.8% | 90,102 | +67.5% | 0.00% | -100.0% |
| Q2 2020 | $1,224,000 | +650.9% | 53,800 | +153.8% | 0.00% | – |
| Q1 2020 | $163,000 | +22.6% | 21,200 | +48.3% | 0.00% | – |
| Q4 2019 | $133,000 | +141.8% | 14,300 | +40.2% | 0.00% | – |
| Q2 2018 | $55,000 | 0.0% | 10,200 | 0.0% | 0.00% | – |
| Q1 2018 | $55,000 | -72.5% | 10,200 | -72.7% | 0.00% | – |
| Q4 2017 | $200,000 | +4.2% | 37,300 | +38.7% | 0.00% | – |
| Q3 2017 | $192,000 | – | 26,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
| MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
| Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
| BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
| NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
| ARK Investment Management | 19,856 | $776,000 | 0.01% |
| HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
| Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |